| Net loss | -21.71K |
| Amortization and depreciation | 3.93K |
| Provision for inventory obsolescence | |
| Non cash expense related to issuance of warrants and granting of stock options | |
| (Increase) decrease in accounts receivable | -233.18K |
| (Increase) decrease in receivable from sale of licenses and intellectual property | |
| (Increase) decrease in inventories | -71.73K |
| (Increase) decrease in other assets | -44.15K |
| (Increase) decrease in deferred taxes | |
| Increase (decrease) in accounts payable | 6.97K |
| Increase (decrease) in accrued liabilities | -195.75K |
| Increase (decrease) in customer deposits | 250 |
| Net cash (used in) provided by operating activities | |
| Investing activities | |
| Payments on contracts payable | |
| Proceeds from secured note payable | |
| Proceeds from bridge loans and bank financings | |
| Payments on bridge loans | |
| Payment on bank financing | |
| Proceeds from sale of common stock | |
| Net cash (used in) provided by financing activities | |
| Net increase (decrease) in cash and cash equivalents | -174.47K |
| Cash and cash equivalents, beginning of period | 237.91K |
| Cash and cash equivalents, end of period | 63.44K |
| Interest | 35.9K |
| Income taxes | |